Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 5 (12) , 2178-2182
Abstract
No abstract availableKeywords
Funding Information
- Sanifit Therapeutics, S.A
This publication has 14 references indexed in Scilit:
- Chronic kidney disease and premature ageingNature Reviews Nephrology, 2014
- Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysisThe Lancet, 2013
- Protocol adherence and the progression of cardiovascular calcification in the ADVANCE studyNephrology Dialysis Transplantation, 2012
- The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysisNephrology Dialysis Transplantation, 2010
- Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysisNature Clinical Practice Cardiovascular Medicine, 2007
- Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium bindersNephrology Dialysis Transplantation, 2006
- Distribution of Coronary Artery Calcium by Race, Gender, and AgeCirculation, 2006
- Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisKidney International, 2005
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method.Radiology, 1998